The relationship between the HDL-associated PON1 activity and the plasma concentration of protein carbonyls, which are products of protein oxidation and also pathogenic mediators of cardiovascular complications, were analyzed in another cross-sectional study with ESRD patients on HD, and type I diabetes subjects without complications [71]. This evidence concerns the gene PON1 and type 1 diabetes mellitus.